The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis

The need for adjuvant therapy after radical resection for patients with stage II–III thoracic esophageal squamous cell carcinoma (TESCC) who have undergone neoadjuvant chemotherapy (NAC) has not been determined. Since recurrence can occur after radical resection and since the prognosis is still poor...

Descripción completa

Detalles Bibliográficos
Autores principales: Imai, Takeharu, Tanaka, Yoshihiro, Sato, Yuta, Mase, Junichi, Suetsugu, Tomonari, Fukada, Masahiro, Yasufuku, Itaru, Iwata, Yoshinori, Mori, Ryutaro, Imai, Hisashi, Kato, Takazumi, Okumura, Naoki, Matsuhashi, Nobuhisa, Takahashi, Takao, Futamura, Manabu, Yoshida, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402973/
https://www.ncbi.nlm.nih.gov/pubmed/34483594
http://dx.doi.org/10.1007/s13193-021-01419-0

Ejemplares similares

Ejemplares similares